K
Keith M. Sullivan
Researcher at Duke University
Publications - 458
Citations - 40788
Keith M. Sullivan is an academic researcher from Duke University. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 105, co-authored 447 publications receiving 39067 citations. Previous affiliations of Keith M. Sullivan include American Cancer Society & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Polymyositis as a manifestation of chronic graft‐versus‐host disease
TL;DR: Myositis in the chronic GVHD population occurred with an incidence higher than expected by chance, suggesting that muscle may be a target tissue for chronic GVsH, and lends support to the possibility that both idiopathic myositis and chronic GvHD-related myositIS could involve allo-autoimmune responses.
Journal ArticleDOI
Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.
Rainer Storb,Paul L. Weiden,Keith M. Sullivan,F R Appelbaum,Patrick G. Beatty,C. D. Buckner,Clift Ra,Kristine Doney,J.A. Hansen,Paul J. Martin +9 more
TL;DR: Successful second transplants after cyclophosphamide and antithymocyte globulin are possible in most patients with aplastic anemia who have rejected their first marrow grafts; however, mortality remains high, with only 40% of the patients becoming long-term survivors.
Journal ArticleDOI
Graft-v-host disease is associated with autoimmune-like thrombocytopenia
TL;DR: It is concluded that persistent thrombocytopenia after marrow transplantation is most often secondary to increased platelet destruction mediated by multiple mechanisms and that platelet autoantibodies are found in patients with acute or chronic GVHD.
Journal Article
Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect.
Celestia S. Higano,M Brixey,Eileen Bryant,D M Durnam,Kristine Doney,Keith M. Sullivan,Jack W. Singer +6 more
Journal ArticleDOI
Immune Recovery in Adult Patients after Myeloablative Dual Umbilical Cord Blood, Matched Sibling, and Matched Unrelated Donor Hematopoietic Cell Transplantation
Junya Kanda,Junya Kanda,Lun Wei Chiou,Paul Szabolcs,Gregory D. Sempowski,David A. Rizzieri,Gwynn D. Long,Keith M. Sullivan,Cristina Gasparetto,John P. Chute,Ashley Morris,Jacalyn McPherson,Jeffrey Hale,John Andrew Livingston,Gloria Broadwater,Donna Niedzwiecki,Nelson J. Chao,Mitchell E. Horwitz +17 more
TL;DR: Compared to HLA-identical matched sibling donor and matched unrelated donor adult hematopoietic cell transplantation recipients, quantitative lymphoid recovery in UCB transplantation recipient is slower in the first 3 months, but these differences disappeared by 6 to 12 months after transplantation.